Articles for Phase Iii

With Phase IV of underground drainage project, coverage will improve to 90% of Tiruchi city
3 months, 2 weeks ago

With Phase IV of underground drainage project, coverage will improve to 90% of Tiruchi city

The Hindu  

Work on Phase IV of the underground drainage project, covering the peripheral areas in the city, is likely to commence within this month. With the implementation of the new project, the official said, the coverage of the underground drainage system in the city would increase to more than 90%. The Corporation, under Phase II, Phase III, and the Smart Cities …

Ward Phase Iii Phase Iii Ugd Project Phase Ii Phase Iv
Delhi Metro revises Sunday timings for lines included in Phase III. Check details
4 months ago

Delhi Metro revises Sunday timings for lines included in Phase III. Check details

Hindustan Times  

The Delhi Metro Rail Corporation on Friday announced new Sunday timings for Phase III lines. Services on all other corridors of the Metro Network will continue to run as per regular commencement time of 06:00 AM onwards.” Here are the details on the revised timings Line Section Present Timings New Timings from Sunday, August 25 Line-1 Dishad Garden to Shaheed …

Delhi Competitive Exams Timings Delhi Metro Phase Iii 7 Am Noida Metro
Star USC scientist faces scrutiny — retracted papers and a paused drug trial
7 months, 1 week ago

Star USC scientist faces scrutiny — retracted papers and a paused drug trial

LA Times  

Late last year, a group of whistleblowers submitted a report to the National Institutes of Health that questioned the integrity of a celebrated USC neuroscientist’s research and the safety of an experimental stroke treatment his company was developing. NIH has since paused clinical trials for 3K3A-APC, a stroke drug Three of Zlokovic’s research papers have been retracted by the journal …

Data Patients Stroke Report Phase Usc Nih
Age Of Livestreaming And Social Media Places New Demands On Judges: Chief Justice Chandrachud
1 year, 7 months ago

Age Of Livestreaming And Social Media Places New Demands On Judges: Chief Justice Chandrachud

Live Law  

The Chief Justice of India D Y Chandrachud speaking at the National Conference on Digitization, Paperless Courts and e-Initiatives organised by the High Court of Orissa, remarked that in the age of livestreaming and social media every word said by judges in court is up in public realm, which places new challenges and demands on judges. Sometimes it may, sometimes …

Social Media India Justice Judges High Courts Age Project
BMRCL to build elevated metro corridor above Delmia Circle flyover to avoid demolition of existing structure
1 year, 10 months ago

BMRCL to build elevated metro corridor above Delmia Circle flyover to avoid demolition of existing structure

The Hindu  

To save Delmia Circle Flyover at J.P. Nagar, the Bangalore Metro Rail Corporation Limited has decided to build the proposed metro corridor under Phase III of Namma Metro above the existing structure. The Delmia Circle Flyover is turning out to be a hindrance for construction of the elevated corridor from Vega City Mall side towards Kanakapura Road. Delmia Circle flyover …

Metro Road Flyover Corridor Build Namma Bmrcl
Bengaluru will have two more road-cum-metro flyovers under phase III of Namma Metro
2 years, 3 months ago

Bengaluru will have two more road-cum-metro flyovers under phase III of Namma Metro

The Hindu  

The city will soon have two more road-cum-metro flyovers. In the proposed Phase III of the Namma Metro line from J.P. Nagar 4th phase to Kempapura, the Bangalore Metro Rail Corporation Limited will construct these road-cum-metro flyovers from Kanakapura Road junction and Sarakki junction over a 1.366 km and another between Kamakya – Ittamadu – Hoskerehalli junction over 1.563 km. …

Metro Road Station Lines Line Phase Stations
Bharat Biotech completes clinical development for phase III trials, booster doses for BBV154 intranasal COVID vaccine
2 years, 4 months ago

Bharat Biotech completes clinical development for phase III trials, booster doses for BBV154 intranasal COVID vaccine

Firstpost  

BBV154 has the double benefit of enabling faster development of variant-specific vaccines and easy nasal delivery that helps mass immunisation protect from emerging concern variants Hyderabad, Telangana: Bharat Biotech International on Monday said that BBV154 has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials. Product development related to preclinical safety evaluation, large-scale manufacturing scale-up, formulation, …

India Development Delivery Trials Product Development Vaccines Clinical Trials
COVID-19 intranasal vaccine Phase III trials over, proven safe, says Bharat Biotech
2 years, 4 months ago

COVID-19 intranasal vaccine Phase III trials over, proven safe, says Bharat Biotech

Deccan Chronicle  

HYDERABAD: Bharat Biotech International Limited on Monday said its COVID-19 intranasal vaccine has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials phase III. Product development related to pre-clinical safety evaluation, large-scale manufacturing scale-up, formulation, and delivery device development, including human clinical trials, was conducted by Bharat Biotech. Suchitra K Ella, Joint Managing Director, Bharat Biotech, …

India Trials Product Development Clinical Trials Covid Vaccine Clinical
How Macaulay Putras Ridiculed Covaxin and Data Proved Them Wrong
3 years, 1 month ago

How Macaulay Putras Ridiculed Covaxin and Data Proved Them Wrong

News 18  

The Phase III human clinical trials of Covaxin began in mid-November 2020, involving 26,000 volunteers, between 18 and 98 years of age, across 21 sites. It was India’s first and only Phase III study for a COVID-19 vaccine, and the largest Phase III efficacy trial ever conducted here for any vaccine. He said that if the East India Company had …

Data Indian Vaccine Icmr Phase Iii Macaulay Covaxin
Biological E gets nod to start Phase III clinical trial of Covid vaccine
3 years, 7 months ago

Biological E gets nod to start Phase III clinical trial of Covid vaccine

India Today  

Biological E. Limited, a Hyderabad-based vaccine and pharmaceutical company, on Saturday announced that it has successfully completed the Phase I and II clinical trials of its Covid-19 vaccine candidate in India. The Coalition for Epidemic Preparedness Innovations and the Biotechnology Industry Research Assistance Council provided support for the Phase I and II clinical trials of BE’s vaccine candidate. We believe …

India Trial Trials Clinical Trials Covid Sec Candidate
'Our Data Open. Don't Drag Us Into Politics. We're Scientists': Bharat Biotech Chiefs Hit out at Detractors
3 years, 11 months ago

'Our Data Open. Don't Drag Us Into Politics. We're Scientists': Bharat Biotech Chiefs Hit out at Detractors

News 18  

As government prepares to launch the vaccination drive against coronavirus on Saturday, Bharat Biotech chairman Dr Krishna Ella said India can expect interim efficacy data on its vaccine once the trials are completed. In an interview to CNN-News18, Dr Ella and Bharat Biotech co-founder and joint MD Suchitra Ella talked about the efficacy data, Covaxin’s availability in markets and its …

Data Trials Hit Sec Niv Virus Ella
Biological E. begins clinical trial of Covid vaccine
4 years, 1 month ago

Biological E. begins clinical trial of Covid vaccine

The Hindu  

Biological E. on Monday said the Phase I/II clinical trial of its COVID-19 subunit vaccine candidate has been initiated in the country. A release from Biological E. said the vaccine candidate includes an antigen in-licensed from BCM Ventures, Baylor College of Medicine’s integrated commercialisation team, along with Dynavax’s advanced adjuvant CpG 1018. BE's Phase I/II clinical trial will evaluate the …

Trial Covid Vaccine Clinical Trial
Coronavirus vaccine update: Moderna says Covid-19 shot 94% effective, Bharat Biotech to start phase III trials
4 years, 1 month ago

Coronavirus vaccine update: Moderna says Covid-19 shot 94% effective, Bharat Biotech to start phase III trials

India Today  

US biotech company Moderna said Monday that its coronavirus vaccine candidate was shown to provide strong protection against the deadly virus. Moderna said interim results from ongoing human trials show that its novel coronavirus vaccine candidate appears to be 94.5 per cent effective in preventing a Covid-19 infection, the deadly disease that has caused a global pandemic. MODERNA ANNOUNCMENT FOLLOWS …

India Coronavirus Trial Trials Vaccines Candidate Human
Coronavirus vaccine: Bahrain frontline workers receive shots of Covid-19
4 years, 1 month ago

Coronavirus vaccine: Bahrain frontline workers receive shots of Covid-19

Live Mint  

Bahrain has started inoculating frontline workers, who are in direct contact with active Covid-19 cases, with a vaccine, state news agency BNA said. The report also said that the programme will be using a shot developed by Chinese state-owned pharmaceutical firm Sinopharm, which is in Phase III trials in the United Arab Emirates, Egypt, Bahrain and Jordan. Bahrain's Health Minister …

Trials Minister Phase Vaccine Bahrain Frontline Workers Coronavirus Vaccine
Covaxin: Bharat Biotech granted permission to start Phase III trials for Covid-19 vaccine
4 years, 2 months ago

Covaxin: Bharat Biotech granted permission to start Phase III trials for Covid-19 vaccine

India Today  

The Drug Controller General of India on Thursday allowed Bharat Biotech International Limited to conduct the Phase III trials of its Covid-19 vaccine candidate Covaxin. The permission for the Phase III trials is subject to minor changes in the primary efficacy endpoint for the symptomatic cases. "The firm has presented their data from Phase I and II along with animal …

India Phase Bharat Biotech Covaxin Phase Iii Trials Trials Granted Phase I
Covid vaccine: Russia may be the first to announce data from final trial
4 years, 2 months ago

Covid vaccine: Russia may be the first to announce data from final trial

Live Mint  

Russia plans to share preliminary results of its COVID-19 vaccine trial based on the first six weeks of monitoring participants, raising the tempo in an already frenzied global race to end the pandemic. The plan to publish interim results based on the first 42 days of monitoring volunteers means Russia has a high chance of becoming the first worldwide to …

Russia Data Volunteers Covid Moscow Vaccine Participants
If a COVID-19 vaccine is found here's how long it will take to get to your GP
4 years, 2 months ago

If a COVID-19 vaccine is found here's how long it will take to get to your GP

ABC  

Australia has shored up access to some leading contenders for a COVID-19 vaccine and while it's hoped some people will get the jab in early 2021, others will have to wait much longer. Phase III: Testing in a larger number of humans to confirm its effectiveness Testing in a larger number of humans to confirm its effectiveness Phase IV: After …

Access Covid Phase Vaccine Humans Oxford Tga
Oxford Covid-19 vaccine phase 3 trials in India may begin on August 22
4 years, 4 months ago

Oxford Covid-19 vaccine phase 3 trials in India may begin on August 22

India Today  

The Union Health Ministry on Tuesday announced that phase III trials of the Oxford vaccine will begin this week in India. Sources have told India Today TV that the phase III trials are likely to begin on Saturday, August 22, and that about a hundred people would be vaccinated on the first day. The phase III trials of the vaccine, …

India Trials Phase Vaccine Oxford India Today Tv Phase Iii Trials
Oxford Covid-19 vaccine phase 3 trials begin in India: What to know
4 years, 4 months ago

Oxford Covid-19 vaccine phase 3 trials begin in India: What to know

India Today  

The Union Health Ministry on Tuesday announced that phase III trials of the Oxford vaccine will begin this week in India. The Oxford vaccine will begin phase III trials at 20 centres in India predominantly in Pune and Mumbai in Maharashtra and Ahmedabad in Gujarat. We seek to conduct trials across 11-12 hospitals in partnership with ICMR," said a spokesperson …

India Price Covid Oxford Vaccine Phase Iii Trials